Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
HRA Pharma and Afaxys join forces on emergency contraceptive ella® in the USA

March 2014

27

HRA Pharma and Afaxys join forces on emergency contraceptive ella® in the USA

October 2013

31

HRA Pharma and Laboratoires Carilene Sign an Exclusive Distribution Agreement for a Product Indicated in the Symptomatic Treatment of Genital Herpes

June 2012

11

Richter and HRA Pharma Expand their Marketing Agreement for Esmya® to Latin America

Février 2012

27

Uliprisrtal Acetate Granted European Marketing Authorisation for the Treatment of Symptoms Of Uterine Fibroids

Février 2012

02

NEJM Features Two Positive Pivotal Trials of HRA Pharma Compound Ulipristal Acetate for the Treatment of Uterine Fibroids

December 2011

05

HRA Pharma grants Richter marketing rights for Esmya for China, Russia and other CIS republics

September 2011

20

First Launch of ellaOne® in Asia

September 2011

20

ella® approved in Singapore

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?